Visby Medical raises up to $65M to commercialize home STI test
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
